NCT02077283

Brief Summary

NAFLD(non-alcoholic fatty liver disease, NAFLD) is a common liver disease with a high morbidity which seriously influence people's health. In clinical, there are two major Traditional chinese medicine(TCM) patterns which are the pattern of "liver depression and spleen deficiency" and pattern of "damp-heat in the interior", According to TCM patterns, the treatment is effective, but not used worldwide. While the development of metabonomics provides a tool to investigate the correlation of TCM patterns and metabonomics which will promote the further development of TCM. Currently researches on NAFLD patterns based on metabolomics were limited. Our study was undertaken to investigate the correlation of TCM patterns and metabonomics, to evaluate the application of urinary metabonomics in NAFLD: whether it can be used in TCM patterns auxiliary classification of NAFLD. In addition, the investigators also aim to discover novel biomarkers for the noninvasive early diagnosis of nonalcoholic fatty liver disease (NAFLD). In this study, urine samples from humans of three divided groups (healthy controls, the group of "liver depression and spleen deficiency" pattern and group of "damp-heat in the interior pattern) were collected, then 4℃, 15 min 3000 rpm centrifuged and - 80℃ cryopreserved. The metabolic profile changes were analyzed by Gas Chromatograph-Mass Spectrometer(GC/MS) with principal component analysis (PCA), partial least squares-discriminate analysis (PLS-DA) and orthogonal partial least squares-discriminate analysis (OPLS-DA). Furthermore, biochemical examination were also carried out to compare among these three groups. Base on literature survey, the investigators inferred that there should be metabolic differences between the two patterns of NAFLD. If the investigators hypothesis is correct, the investigators can find different metabolites which can be used discriminate between NAFLD and healthy population, different patterns through urinary metabonomics. The results will be attractive which mean a lot: it will prove the importance of the four diagnosis methods of TCM used in differential analysis by metabonomics; it will validate the classification of TCM syndromes is scientific; it will shed light in the study of TCM syndromes; it will find biology markers to help diagnosis, treatment and pattern discrimination.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
114

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 4, 2014

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

November 20, 2015

Status Verified

November 1, 2015

Enrollment Period

2.8 years

First QC Date

February 26, 2014

Last Update Submit

November 19, 2015

Conditions

Keywords

NAFLD (non-alcoholic fatty liver disease, NAFLD)urinary metabonomicsTCM pattern"liver depression and spleen deficiency" pattern,"damp-heat in the interior" pattern

Outcome Measures

Primary Outcomes (1)

  • metabolites

    Urine samples of patients will be collected when they come to outpatient service. Then the urine metabolic profile changes will be analyzed by GC/MS and be manifested through different metabolites.

    5 months

Study Arms (3)

Healthy people

This group contains healthy people only whose liver function and B ultrasound are normal.

group of "liver depression and spleen deficiency" pattern

In this group, patients are considered to be the pattern of "liver depression and spleen deficiency". They mainly have the symptoms of loose stool, depression, fat tongue with white coating and teeth marks and soft or string pulse.

group of "damp-heat in the interior" pattern.

In this group ,NAFLD patients have symptoms with dry mouth, bitter mouth, heavy feeling in legs, yellow urine, reddish tongue with thick yellowish coating and slippery pulse.

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

All patients will be enrolled in NAFLD outpatient of Shuguang hospital. The healthy people also will be enrolled in Shuguang hospital.

You may qualify if:

  • The existence of fat in liver parenchyma scatters the beam of ultrasound more than a non-fatty liver. Although ultrasonography might have some limitations for the grading of NAFLD, its availability makes it an appropriate tool for NAFLD screening.The radiologist was not informed about the clinical.
  • NAFLD indicates the lack of any evidence of ongoing or recent consumption of significant quantities of alcohol.
  • Both genders between the ages of 18-60 years, eligible for study through a screening test confirming the presence of NAFLD as defined above.
  • Based on tongue, pulse conditions and other four diagnostic information, the NAFLD patients who have the symptoms which can be recognized as "liver depression and spleen deficiency" pattern or "damp-heat in the interior" pattern.

You may not qualify if:

  • History of diabetes mellitus or any metabolic disease
  • Alcohol consumption \> 20 g/day.
  • Presently having acute diseases or other untreated illness requiring treatment.
  • Impaired hepatic or renal functions.
  • Lactation, pregnancy or unwillingness to use an effective form of birth control for women of childbearing years.
  • History or presence of any condition, in the investigator's opinion, that would endanger the individual's safety or affect the study result.
  • If any of conditions above exists, the subjects were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Liver Disease, ShuGuang Hospital, Shanghai University of TCM.

Shanghai, 201203, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

midstream urina sanguinis

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Study Officials

  • mingyu Sun, PhD

    Institute of Liver Disease, ShuGuang Hospital, Shanghai University of TCM

    STUDY DIRECTOR

Central Study Contacts

mingyu Sun, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctoral student

Study Record Dates

First Submitted

February 26, 2014

First Posted

March 4, 2014

Study Start

January 1, 2014

Primary Completion

November 1, 2016

Study Completion

November 1, 2017

Last Updated

November 20, 2015

Record last verified: 2015-11

Locations